Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MIGUEL A ESCOBAR

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1437177912
CMS profile
336853
Location
HOUSTON, TX

General Payments · PY2018–2024

$827,216.03

  • Reported across 499 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$60,098.89

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $34,148.77 7
HEMA Biologics, LLC $14,146.62 14
CSL Behring $7,913.10 4
Samsung Bioepis Co., Ltd. $2,040.00 1
PFIZER INC. $1,525.11 2
Genentech USA, Inc. $200.29 2
Novo Nordisk AS $125.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $134,962.44 54
PY2019 $130,920.86 74
PY2020 $92,697.53 53
PY2021 $105,236.39 62
PY2022 $126,272.81 90
PY2023 $177,027.11 135
PY2024 $60,098.89 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
CSL Behring $5,475.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1134614727 CMS
CSL Behring $294.60 03/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1134614731 CMS
CSL Behring $823.80 06/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1134614733 CMS
CSL Behring $1,319.70 07/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1134614735 CMS
Genentech USA, Inc. $121.68 02/08/2024 Food and Beverage Undisputed 01/23/2026 1133072877 CMS
Genentech USA, Inc. $78.61 04/22/2024 Food and Beverage Undisputed 01/23/2026 1133072881 CMS
GENZYME CORPORATION $7,294.40 02/27/2024 Consulting Fee Undisputed 01/23/2026 1139653305 CMS
GENZYME CORPORATION $87.41 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139653307 CMS
GENZYME CORPORATION $47.90 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139653309 CMS
GENZYME CORPORATION $72.46 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139653311 CMS
GENZYME CORPORATION $355.35 02/27/2024 Travel and Lodging Undisputed 01/23/2026 1139653313 CMS
GENZYME CORPORATION $26,171.25 06/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139653337 CMS
GENZYME CORPORATION $120.00 06/06/2024 Travel and Lodging Undisputed 01/23/2026 1139653339 CMS
HEMA Biologics, LLC $3,350.00 01/02/2024 Honoraria Undisputed 01/23/2026 1152821405 CMS
HEMA Biologics, LLC $4,020.00 01/02/2024 Consulting Fee Undisputed 01/23/2026 1152821407 CMS
HEMA Biologics, LLC $692.20 03/05/2024 Travel and Lodging Undisputed 01/23/2026 1152821273 CMS
HEMA Biologics, LLC $5,000.00 03/23/2024 Consulting Fee Undisputed 01/23/2026 1152821275 CMS
HEMA Biologics, LLC $277.75 03/23/2024 Travel and Lodging Undisputed 01/23/2026 1152821279 CMS
HEMA Biologics, LLC $17.43 03/23/2024 Travel and Lodging Undisputed 01/23/2026 1152821281 CMS
HEMA Biologics, LLC $5.87 03/23/2024 Food and Beverage Undisputed 01/23/2026 1152821283 CMS
HEMA Biologics, LLC $224.73 03/23/2024 Travel and Lodging Undisputed 01/23/2026 1152821325 CMS
HEMA Biologics, LLC $57.25 03/23/2024 Food and Beverage Undisputed 01/23/2026 1152821331 CMS
HEMA Biologics, LLC $116.86 03/23/2024 Food and Beverage Undisputed 01/23/2026 1152821333 CMS
HEMA Biologics, LLC $88.14 03/23/2024 Food and Beverage Undisputed 01/23/2026 1152821339 CMS
HEMA Biologics, LLC $127.57 03/23/2024 Food and Beverage Undisputed 01/23/2026 1152821341 CMS
HEMA Biologics, LLC $13.98 03/24/2024 Travel and Lodging Undisputed 01/23/2026 1152821287 CMS
HEMA Biologics, LLC $154.84 04/23/2024 Food and Beverage Undisputed 01/23/2026 1152821295 CMS
Novo Nordisk Inc $125.00 06/23/2024 Food and Beverage Undisputed 01/23/2026 1097608439 CMS
PFIZER INC. $25.11 04/21/2024 Food and Beverage Undisputed 01/23/2026 1132131687 CMS
PFIZER INC. $1,500.00 05/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131595331 CMS
Samsung Bioepis Co., Ltd. $2,040.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 1149333116 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.